Importer of Controlled Substances Application: United States Pharmacopeial Convention, 43603 [2020-15465]
Download as PDF
<![CDATA[
43603
Federal Register / Vol. 85, No. 138 / Friday, July 17, 2020 / Notices
INTERNATIONAL TRADE
COMMISSION
[Investigation Nos. 701–TA–626 and 731–
TA–1452 (Final)]
Certain Collated Steel Staples From
China
Determinations
On the basis of the record 1 developed
in the subject investigations, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to the Tariff Act of 1930 (‘‘the Act’’),
that an industry in the United States is
materially injured by reason of imports
of certain collated steel staples from
China, provided for in subheading
8305.20.0000 of the Harmonized Tariff
Schedule of the United States, that have
been found by the U.S. Department of
Commerce (‘‘Commerce’’) to be sold in
the United States at less than fair value
(‘‘LTFV’’), and to be subsidized by the
government of China.2
Background
khammond on DSKJM1Z7X2PROD with NOTICES
The Commission instituted these
investigations effective June 6, 2019,
following receipt of petitions filed with
the Commission and Commerce by
Kyocera Senco Industrial Tools, Inc.
(‘‘Senco’’), Cincinnati, Ohio. The final
phase of the investigations was
scheduled by the Commission following
notification of preliminary
determinations by Commerce that
imports of certain collated steel staples
from China were subsidized within the
meaning of section 703(b) of the Act (19
U.S.C. 1671b(b)) and sold at LTFV
within the meaning of 733(b) of the Act
(19 U.S.C. 1673b(b)). Notice of the
scheduling of the final phase of the
Commission’s investigations and of a
public hearing to be held in connection
therewith was given by posting copies
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register on January 21, 2020 (85 FR
3417). In light of the restrictions on
access to the Commission building due
to the COVID–19 pandemic, and in
accordance with 19 U.S.C. 1677c(a)(1),
the Commission conducted its hearing
via video conference on May 27, 2020;
all persons who requested the
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
2 The Commission also finds that imports subject
to Commerce’s affirmative critical circumstances
determination are not likely to undermine seriously
the remedial effect of the countervailing and
antidumping duty orders on certain collated steel
staples from China.
VerDate Sep<11>2014
18:12 Jul 16, 2020
Jkt 250001
opportunity were permitted to
participate.
The Commission made these
determinations pursuant to sections
705(b) and 735(b) of the Act (19 U.S.C.
1671d(b) and 19 U.S.C. 1673d(b)). It
completed and filed its determinations
in these investigations on July 13, 2020.
The views of the Commission are
contained in USITC Publication 5085
(July 2020), entitled Certain Collated
Steel Staples from China: Investigation
Nos. 701–TA–626 and 731–TA–1452
(Final).
By order of the Commission.
Issued: July 13, 2020.
Lisa Barton,
Secretary to the Commission.
following basic class(es) of a controlled
substance:
Controlled substance
Methcathinone ..........................
Drug
code
Schedule
1237
I
The company plans to import the
listed controlled substance for
distribution of analytical reference
standards to its customers for analytical
testing of raw materials. No other
activities for this drug code are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–15465 Filed 7–16–20; 8:45 am]
BILLING CODE P
[FR Doc. 2020–15457 Filed 7–16–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–669]
[Docket No. DEA–682]
Importer of Controlled Substances
Application: Cambrex Charles City
Importer of Controlled Substances
Application: United States
Pharmacopeial Convention
ACTION:
Notice of application.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 17, 2020. Such persons
may also file a written request for a
hearing on the application on or before
August 17, 2020.
DATES:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 17, 2020. Such persons
may also file a written request for a
hearing on the application on or before
August 17, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on June 17, 2020, United
States Pharmacopeial Convention, 7135
English Muffin Way, Frederick,
Maryland 21704, applied to be
registered as an importer of the
DATES:
ACTION:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2020, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616, applied to be
registered as an importer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Page 43603]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15465]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-682]
Importer of Controlled Substances Application: United States
Pharmacopeial Convention
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 17, 2020.
Such persons may also file a written request for a hearing on the
application on or before August 17, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on June 17, 2020, United States Pharmacopeial
Convention, 7135 English Muffin Way, Frederick, Maryland 21704, applied
to be registered as an importer of the following basic class(es) of a
controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Methcathinone........................... 1237 I
------------------------------------------------------------------------
The company plans to import the listed controlled substance for
distribution of analytical reference standards to its customers for
analytical testing of raw materials. No other activities for this drug
code are authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-15465 Filed 7-16-20; 8:45 am]
BILLING CODE P
